The PET tracers showed higher detection rates of prostate cancer than MRI, with 89Zr‐df‐IAB2M being superior to 68Ga‐PSMA‐11 in terms of sensitivity, specificity, and accuracy. This evidence concerns the gene FOLH1 and prostate carcinoma.